PTPN22 R620W polymorphism in the ANCA-associated vasculitides

Rheumatology

Volumn 51, Issue 5, 2012, Pages 805-812

  Martorana, Davide ^a   Maritati, Federica ^b   Malerba, Giovanni ^c   Bonatti, Francesco ^a   Alberici, Federico ^b   Oliva, Elena ^b   Sebastio, Paola ^a   Manenti, Lucio ^b   Brugnano, Rachele ^d   Catanoso, Maria G ^e   Fraticelli, Paolo ^f   Guida, Giuseppe ^g   Gregorini, Gina ^h   Possenti, Stefano ^h   Moroni, Gabriella ⁱ   Leoni, Antonio ⁱ   Pavone, Laura ⁱ   Pesci, Alberto ^j   Sinico, Renato A ^k   Di Toma, Lucafrancesco ^l   D'Amico, Marco ^m   Tumiati, Bruno ^e   D'Ippolito, Raffaele ⁿ   Buzio, Carlo ^b   Neri, Tauro M ^a   Vaglio, Augusto ^b   more..

^a Genetics and Molecular Biology Unit   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^e S MARIA NUOVA HOSPITAL   (Italy)

^f OSPEDALI RIUNITI   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h SPEDALI CIVILI   (Italy)

ⁱ FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^j UNIVERSITY OF MILANO BICOCCA   (Italy)

^k SAN CARLO BORROMEO HOSPITAL   (Italy)

^l Legnano Hospital   (Italy)

^m SANT ANNA HOSPITAL   (Italy)

ⁿ UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

more..

Author keywords

ANCA; Autoimmunity; Granuloma; Granulomatosis with polyangiitis; PTPN22; Vasculitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ADOLESCENT; ADULT; AGED; ARTICLE; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LABORATORY TEST; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22;

EID: 84860254393     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker446     Document Type: Article

References (49)

1. Kallenberg CG. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Curr Opin Rheumatol 2007;19:17-24.
2. Pavone L, Grasselli C, Chierici E et al. Outcome and prognostic factors during the course of primary small-vessel vasculitides. J Rheumatol 2006;33:1299-306.
3. Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of disease: pathogenesis and treatment of ANCAassociated vasculitides. Nat Clin Pract Rheumatol 2006;2: 661-70.
4. Lane SE, Watts RA, Bentham G et al. Are environmental factors important in primary systemic vasculitis? A case-control study. Arthritis Rheum 2003;48:814-23.
5. Scott DG, Watts RA. Systemic vasculitis: epidemiology, classification and environmental factors. Ann Rheum Dis 2000;59:161-3.
6. Carr EJ, Niederer HA, Williams J et al. Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis. BMC Med Genet 2009;10: 121.
7. Vaglio A, Casazza I, Grasselli C et al. Churg-Strauss syndrome. Kidney Int 2009;76:1006-11.
8. Wieczorek S, Holle JU, Epplen JT. Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome. Curr Opin Rheumatol 2010;22:8-14.
9. Willcocks LC, Lyons PA, Rees AJ et al. The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis. Arthritis Res Ther 2010;12:202.
10. Brand O, Gough S, Heward J. HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev Mol Med 2005;7:1-15.
11. Vang T, Miletic AV, Arimura Y et al. Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol 2008; 26:29-55.
12. Vang T, Congia M, Macis MD et al. Autoimmuneassociated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37:1317-9.
13. Lee YH, Rho YH, Choi SJ et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology 2007;46:49-56.
14. Latiano A, Palmieri O, Valvano MR et al. Evaluating the role of the genetic variations of PTPN22, NFKB1, and FcGRIIIA genes in inflammatory bowel disease: a meta-analysis. Inflamm Bowel Dis 2007;13:1212-9.
15. Arechiga AF, Habib T, He Y et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol 2009;182:3343-7.
16. Jagiello P, Aries P, Arning L et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005;52:4039-43.
17. Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
18. Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1101-7.
19. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
20. Watts R, Lane S, Hanslik T et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007; 66:222-7.
21. Ribi C, Cohen P, Pagnoux C et al. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum 2008;58: 586-94.
22. Stone JH, Merkel PA, Spiera R et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010;363:221-32.
23. Sinico RA, Di Toma L, Maggiore U et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005;52: 2926-35.
24. Vaglio A, Martorana D, Maggiore U et al. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum 2007;56:3159-66.
25. Bottini N, Musumeci L, Alonso A et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36:337-8.
26. Gregersen PK. Gaining insight into PTPN22 and autoimmunity. Nat Genet 2005;37:1300-2.
27. Gregersen PK, Lee HS, Batliwalla F et al. PTPN22: setting thresholds for autoimmunity. Semin Immunol 2006;18: 214-23.
28. Begovich AB, Carlton VE, Honigberg LA et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004;75:330-7.
29. Orozco G, Sanchez E, Gonzalez-Gay MA et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005;52:219-24.
30. Carlton VE, Hu X, Chokkalingam AP et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005;77:567-81.
31. Michou L, Lasbleiz S, Rat AC et al. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci USA 2007; 104:1649-54.
32. Pierer M, Kaltenhauser S, Arnold S et al. Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients. Arthritis Res Ther 2006;8:R75.
33. Hinks A, Barton A, John S et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 2005; 52:1694-9.
34. Hinks A, Worthington J, Thomson W. The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis. Rheumatology 2006;45:365-8.
35. Viken MK, Amundsen SS, Kvien TK et al. Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 2005;6:271-3.
36. Kaufman KM, Kelly JA, Herring BJ et al. Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum 2006;54:2533-40.
37. Wu H, Cantor RM, Graham DS et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 2005;52:2396-402.
38. Heward JM, Brand OJ, Barrett JC et al. Association of PTPN22 haplotypes with Graves' disease. J Clin Endocrinol Metab 2007;92:685-90.
39. Vandiedonck C, Capdevielle C, Giraud M et al. Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. Ann Neurol 2006;59:404-7.
40. LaBerge GS, Bennett DC, Fain PR et al. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Invest Dermatol 2008;128:1757-62.
41. Chan AT, Flossmann O, Mukhtyar C et al. The role of biologic therapies in the management of systemic vasculitis. Autoimmun Rev 2006;5:273-8.
42. Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-62.
43. Wieczorek S, Hoffjan S, Chan A et al. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun 2009;10: 591-5.
44. Huang D, Giscombe R, Zhou Y et al. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis. J Rheumatol 2000;27:397-401.
45. Wieczorek S, Hellmich B, Arning L et al. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis. Arthritis Rheum 2008;58:1839-48.
46. Polychronopoulos VS, Prakash UB, Golbin JM et al. Airway involvement in Wegener's granulomatosis. Rheum Dis Clin North Am 2007;33:755-75, vi.
47. Lamprecht P, Gross WL. Current knowledge on cellular interactions in the WG-granuloma. Clin Exp Rheumatol 2007;25:S49-51.
48. Komocsi A, Lamprecht P, Csernok E et al. Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol 2002;160:1717-24.
49. Hasegawa K, Martin F, Huang G et al. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004;303:685-9.